对于声门上型喉癌是保守性单一方式的治疗还是联合治疗目前仍有争论。美国得克萨斯州安得森癌中心自1974年至1987年收治的404例声门上鳞癌,211例(52%)进行放疗,主要对象是T_1和部分T_2患者;全喉切除术125例(31%),主要是T_3和T_4部分患者。本文重点分析60例患者(15%),以声门上喉切除及颈前淋巴结清扫为主要治疗方式,选择对象主要是T_2和T_3部分病人,其中50例(83%)辅以术后放疗,其指征是标本边缘病理有阳性发现,向喉外发展和颈淋巴结肿大等,2年无瘤存活率为96%;5年存活率为91%;没有局部复发。3 There is still controversy over whether the supraglottic laryngeal cancer is a conservative single treatment or combination therapy. 404 Sinusoidal squamous cell carcinomas and 211 (52%) patients were treated with radiotherapy at the Anderson Cancer Center in Texas from 1974 to 1987. The main target was T_1 and some T_2 patients; 125 patients underwent total laryngectomy (31 %), mainly in patients with T_3 and T_4. This article focuses on the analysis of 60 patients (15%), with supraglottic resection and anterior cervical lymph node dissection as the main treatment, the main selection of patients is T_2 and T_3 part of the patients, of which 50 patients (83%) supplemented by postoperative radiotherapy, The indications are the positive findings of specimen marginal pathology, development outside the larynx, and cervical lymphadenopathy. The 2-year disease-free survival rate was 96%; the 5-year survival rate was 91%; there was no local recurrence. 3